GlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...

The Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...

University of Florida scientists have engineered an experimental mRNA vaccine that stimulates the immune system to combat tumors in conjunc...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company. The deal invo...

Sun Pharmaceuticals will acquire Checkpoint Therapeutics for $355 million, bringing the FDA-approved anti-PD-L1 treatment for advanced cuta...

Could antiparasitic drugs like ivermectin and fenbendazole help fight cancer? Actor Mel Gibson thinks so. On Joe Rogan's podcast, the Brave...

Mankind Pharma has partnered with Innovent Biologics to bring sintilimab, a PD-1 immunotherapy, to India. The drug treats various cancers a...

In a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...

Immunotherapy should be given as early as possible to achieve a lasting remission of the disease.

The duo showed how different strategies for inhibiting brakes on the immune system that can be used in cancer treatment.

Tokyo, Aug 26 (IANS) Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignan...

Kulkarni, Sengupta and their colleagues have found a method to watch cancer cells in the body die in real time, as a patient is treated wit...

These nanoparticles are then loaded into microneedles, which are arrayed on the surface of a patch. When the patch is applied to a melanoma...

Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to ...

Using a popular genome-editing system, scientists have for the first time devised a new strategy to precisely modify human T-cells, also ca...

Merck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...

The drug has shown early potential as an effective treatment for non-small cell lung cancer, the leading cause of cancer death worldwide.